Aquestive Therapeutics (AQST) Analyst & Key Data

Analyst Consensus

Buy4 analysts

Buy

Updated Sep 12, 2026

Total Analysts4

Buy

10

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$4.78

Median Target+114.44%

$10.25

Potential upside vs current price

DCF Value-145.66%

-$2.18

Potential downside vs current price

Current Stock Price

$4.78

Median Target+114.44%

$10.25

Potential upside vs current price

DCF Value-145.66%

-$2.18

Potential downside vs current price

Analyst Consensus

Buy4 analysts

Buy

Updated Sep 12, 2026

Total Analysts4

Buy

10

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$4.78

Median Target+114.44%

$10.25

Potential upside vs current price

DCF Value-145.66%

-$2.18

Potential downside vs current price

Current Stock Price

$4.78

Median Target+114.44%

$10.25

Potential upside vs current price

DCF Value-145.66%

-$2.18

Potential downside vs current price

Aquestive Therapeutics, Inc.